Michael Johnson, MD
Colon & Rectal Surgery · Kettering, OHNPI 1043482797
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,824 of the $2,282 with a category attached, or 80.0%. Intuitive Surgical accounts for 80.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,875 and has fallen 89.8% since, to $192 in 2025.
Across 20 payments — averaging $114.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Integra Lifesciences Corporation$212
- Medline Industries LP$104
- GE HealthCare$52
- Avita Medical Americas, LLC$36
- Boston Scientific$31
- plus $23 from 2 others
What the payments were for
- Travel & lodging$1,82480%
- Food & beverage$45720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,824 |
| Integra Lifesciences Corporation | 6 | $212 |
| Medline Industries LP | 1 | $104 |
| GE HealthCare | 1 | $52 |
| Avita Medical Americas, LLC | 1 | $36 |
| Boston Scientific | 2 | $31 |
| Axonics, Inc. | 1 | $11 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,767
How this compares
$2,282 in reported general payments places this provider in the 60th percentile of 101 colon & rectal surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 57 | $330 |
| Metronidazole | 62 | $250 |
| Ondansetron OdtOndansetron | 30 | $104 |
| Oxycodone Hcl | 16 | $43 |
| Ciprofloxacin Hcl | 16 | $42 |
| Tramadol Hcl | 16 | $20 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Kettering
- Janice RaffertyCincinnati$164K
- Vincent ObiasCleveland$124K
- David RosenCleveland$102K
- Jean AshburnCleveland$81K
- Matthew KaladyColumbus$66K
- Anna SpivakCleveland$54K
- Scott SteeleCleveland$28K
- Michael LiuCleveland$18K
- Conor DelaneyCleveland$16K
- Gennaro LabellaMason$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.